Skip to content
Screener

Celldex Therapeutics CLDX Service — Revenue

Other product segments

Grant
$15K-97.9%

Similar metrics at other companies

Ribbon Communications Inc. logo
RBBNService Revenue Professional Services — Revenue
$30.83M-6.2%
GigaCloud Technology logo
GCTService revenues — Revenue
$120.83M+24.7%
Itron logo
ITRIService revenues — Revenue
$109.44M+22.2%
Seaboard logo
SEBProduct And Service Other Services — Revenue
$23M+15.0%
Bakkt logo
BKKTService revenue — Revenue
$197K+1,213%
Eos Energy Enterprises, Inc. logo
EOSEService revenue — Revenue
$1.03M-13.0%

Other financials

Income statement

See full
Revenue$22.0K-97.0%
Operating income-$80.6M-26.3%
Net income-$73.5M-29.9%
EPS (diluted)-$0.94-10.6%

Balance sheet

See full
Cash & equivalents$47.5M+106%
Total debt$4.9M+61.8%
Total equity$714.6M+9.0%
Total assets$782.3M+13.0%

Cash flow

See full
Operating cash flow-$57.4M-30.5%
CapEx$3.2M+337%
Free cash flow-$60.6M-35.4%

Valuation

See full
Market cap$3.26B+129%
Enterprise value$3.22B+129%
P/S20,646.4×+20,401×

Profitability

See full
Operating margin-206,220.3%-210,440pp
Net margin-190,220.9%-193,797pp
FCF margin-153,231%-156,630pp

Returns & leverage

See full
Return on equity-43.9%+70.0pp
Debt / equity0.0×
Current ratio11.8×-7.8×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091984
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Revenues:
Product development and licensing agreements$7$7$7$57
Contracts and grants15723301,367
Total revenues22730371,424
Operating expenses:
Research and development67,54254,196140,543106,810
General and administrative13,10310,39124,55221,211
Total operating expenses80,64564,587165,095128,021

Item 1. Unaudited Financial Statements

FAQ

What is Celldex Therapeutics's service — revenue?
Celldex Therapeutics (CLDX) reported service — revenue of $7K in Q2 2026.
How has Celldex Therapeutics's service — revenue changed year-over-year?
Celldex Therapeutics's service — revenue decreased by 0.0% year-over-year, from $7K to $7K.
What is the long-term trend for Celldex Therapeutics's service — revenue?
Over 4 years (2021 to 2025), Celldex Therapeutics's service — revenue has grown at a 33.0% compound annual growth rate (CAGR), from $31K to $97K.
What does service — revenue mean?
This metric represents the total gross revenue generated from service-based contracts with customers, excluding any sales-related taxes collected. It serves as a primary indicator of the commercial traction and demand for the company's specialized service offerings within its business segments. Monitoring this figure helps investors assess the top-line growth contribution of service activities independent of tax-related accounting variations.

Ask your AI about Celldex Therapeutics's service — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude